These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5201592)

  • 41. Prognostic value of plasma fibrinogen in myocardial infarction.
    Gopal R; Saxena KK; Gupta B; Srivastava SS; Srivastava RK; Prasad DN
    J Postgrad Med; 1983 Oct; 29(4):233-5. PubMed ID: 6672181
    [No Abstract]   [Full Text] [Related]  

  • 42. [Study of behaviour of fibrinogen and of some glycoproteins in arteriosclerotic clinical situations (author's transl)].
    Sarno A; La Bruzzo S; Catania A; Francavilla G; Romano A; Caimi G
    G Ital Cardiol; 1980; 10(1):65-71. PubMed ID: 7461310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
    Cavusoglu Y; Gorenek B; Alpsoy S; Unalir A; Ata N; Timuralp B
    Isr Med Assoc J; 2001 Jan; 3(1):13-6. PubMed ID: 11344793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Plasma fibrinogen during the acute stage of angina or myocardial infarct].
    de la Llata-Romero M; Cancino C; Cuan V; López-Santibáñez J; Silvia Oropeza E; Ariza-Andraca H
    Gac Med Mex; 1997; 133(3):175-80; discussion 181. PubMed ID: 9303865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes of fibrinogen concentration and their prognostic value in acute myocardial infarct].
    Judkiewicz L; Bolińska H; Khawam E; Wasiak-Radzikowska M; Niewiarowska J
    Pol Tyg Lek; 1981 Jul; 36(27):1003-5. PubMed ID: 7301647
    [No Abstract]   [Full Text] [Related]  

  • 46. [Changes of fibrinogenemia in myocardial infarct and coronary insufficiency].
    DJORDJEVIC BS; STRASER T
    Srp Arh Celok Lek; 1961 Feb; 89():127-30. PubMed ID: 13723181
    [No Abstract]   [Full Text] [Related]  

  • 47. [Qualitative changes in fibrinogen in rheumatism and coronary insufficiency].
    Mikhalev ID
    Ter Arkh; 1966 Apr; 38(4):37-40. PubMed ID: 5984660
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hemorrheological changes in ischemic heart disease].
    Forconi S; Guerrini M; Pieragalli D; Acciavatti A; Del Bigo C; Galigani C; Di Perri T
    Ric Clin Lab; 1983; 13 Suppl 3():195-208. PubMed ID: 6672996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated high molecular weight fibrinogen in plasma is predictive of coronary ischemic events after acute myocardial infarction.
    Reganon E; Vila V; Ferrando F; Martínez-Sales V; Fayos L; Ruano M; Aznar J
    Thromb Haemost; 1999 Nov; 82(5):1403-5. PubMed ID: 10595627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The characteristics of the interrelation between the hemostatic system and the fibronectin level in patients with ischemic heart disease].
    Kanskaia NV; Karpov RS; Krasheninina TV; Mikhaĭlova VM; Roman'ko OIu; Bykova MIu; Garganeeva NP
    Ter Arkh; 1990; 62(8):54-6. PubMed ID: 2274870
    [No Abstract]   [Full Text] [Related]  

  • 51. [State of the blood coagulation and anti-coagulation system in patients with chronic coronary insufficiency in the post-infarct period].
    Chernysheva GV
    Kardiologiia; 1971 Feb; 11(2):33-5. PubMed ID: 5568387
    [No Abstract]   [Full Text] [Related]  

  • 52. [Intestinal obstruction syndrome as a complication of prolonged anticoagulant treatment].
    Sarris M; Georgoulis J; Gatos M; Zervos SN
    Schweiz Med Wochenschr; 1974 Oct; 104(42):1480-2. PubMed ID: 4547853
    [No Abstract]   [Full Text] [Related]  

  • 53. [Changes in hemostasis in ischemic heart disease].
    Hromec A; Okrucká A; Murín J; Kasper J
    Bratisl Lek Listy; 1993 Mar; 94(3):119-25. PubMed ID: 8353751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma fibrinogen levels as an indicator of myocardial necrosis.
    Cristal N; Slonim A; Hagay Z; Silverman C; Ronen M; Hart A
    J R Coll Physicians Lond; 1982 Jan; 16(1):57-9. PubMed ID: 7062312
    [No Abstract]   [Full Text] [Related]  

  • 55. [Circulation time of 125I-labeled fibrinogen in patients with ischemic heart disease with different types of hyperlipoproteinemia].
    Liusov VA; Belousov IuB; Dudaev VA; Shmushkovich BI
    Kardiologiia; 1976 Apr; 16(4):49-53. PubMed ID: 1030755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The value of anticoagulant therapy in the treatment of acute myocardial infarction.
    McCLUSKIE JA; SEATON DA
    Scott Med J; 1959 Jun; 4(6):305-9. PubMed ID: 13668583
    [No Abstract]   [Full Text] [Related]  

  • 57. [Coronary disease and the "accessory" pre-beta band: a causal relationship?].
    Pagnan A; Donadon W; Tonolli E
    Minerva Med; 1974 Sep; 65(60):3123-6. PubMed ID: 4371402
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluation of anticoagulant therapy in focal ischemic cerebrovascular disease: further observations.
    Siekert RG
    Res Publ Assoc Res Nerv Ment Dis; 1966; 41():359-66. PubMed ID: 4163329
    [No Abstract]   [Full Text] [Related]  

  • 59. [A study of the mucopolysaccharide-thrombogenic mechanism predisposing to myocardial infarct].
    Ol'shevski V; St Liaskovski
    Ter Arkh; 1969 Jul; 41(7):71-7. PubMed ID: 4244773
    [No Abstract]   [Full Text] [Related]  

  • 60. [Blood lipid content and the coagulation system in coronary insufficiency in young persons].
    Uspenskaia VG
    Kardiologiia; 1973 Sep; 13(9):54-8. PubMed ID: 4775811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.